GEV vs MRK: Which Is the Better Buy?
Side-by-side comparison of GE Vernova Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-25.
GE Vernova Inc. · Industrials
$1,014.75
-16.2% upside to fair value
Med Conviction
Grade C+
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
MRK has more upside to fair value
(-12.1%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GEV |
MRK |
| Current Price |
$1,014.75 |
$113.87 |
| Fair Value Estimate |
$850.00 |
$100.14 |
| Upside to Fair Value |
-16.2%
|
-12.1%
|
| Market Cap |
$270.3B |
$281.2B |
| Forward P/E |
34.3x
|
32.0x
|
| EV / EBITDA |
25.6x
|
17.3x
|
| Price / Sales |
6.6x
|
4.3x
|
| Price / FCF |
22.0x
|
19.9x
|
| Revenue Growth YoY |
+15.0%
|
+4.3%
|
| Gross Margin |
21.3%
|
75.9%
|
| Operating Margin |
5.9%
|
27.6%
|
| Return on Equity |
30.0%
|
17.9%
|
| Dividend Yield |
0.17% |
0% |
| FCF Yield |
4.5%
|
5.02%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
GE Vernova is the premier pure-play on the electricity side of the AI infrastructure supercycle. Its Power (heavy-duty gas turbines) and Electrification (grid equipment) segments are structurally supply-constrained, backed by a record $176B backlog that management says is 'mostly sold out through 2030.' The company raised FY2026 guidance for a second straight quarter to $45.5-46.5B revenue and $1…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
GEV |
MRK |
| Zone Low |
$640.00 |
$75.11 |
| Zone High |
$723.00 |
$85.12 |
| In Buy Zone? |
No
|
No
|